...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trial

That is interesting.... How long now have they been on the drug and are still alive....is it 2 or 2  1/2 years....   I can's see how a BP would not be all over this being not blinded

Share
New Message
Please login to post a reply